Jean-Louis Falco
Vorstandsvorsitzender bei CliniGenetics SA
Aktive Positionen von Jean-Louis Falco
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
CliniGenetics SA
 CliniGenetics SA Pharmaceuticals: MajorHealth Technology CliniGenetics SA discovers and develops novel therapeutics for the treatment of cardiovascular, cerebrovascular, and lower limb ischemic diseases. The firm identifies and develops new pathways and products for the treatment of vascular diseases. CliniGenetics was founded in 2000 and is headquartered in Nimes, France. | Vorstandsvorsitzender | - | - |
| Gründer | 17.12.2009 | - | |
| Aurex SAS | Vorsitzender | - | - |
| SAS Linerbenne | Vorsitzender | - | - |
Karriereverlauf von Jean-Louis Falco
Ehemalige bekannte Positionen von Jean-Louis Falco
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Arteria SA (France) | Vorstandsvorsitzender | - | - |
| BLEECKER | Direktor/Vorstandsmitglied | 28.06.2007 | - |
| Independent Dir/Board Member | 28.06.2007 | - |
Ausbildung von Jean-Louis Falco
| Université Paris Dauphine-PSL | Graduate Degree |
Statistik
International
| Frankreich | 7 |
Operativ
| Chief Executive Officer | 2 |
| Chairman | 2 |
| Founder | 1 |
Sektoral
| Finance | 2 |
| Health Technology | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BLEECKER | Finance |
| Private Unternehmen | 4 |
|---|---|
CliniGenetics SA
CliniGenetics SA Pharmaceuticals: MajorHealth Technology CliniGenetics SA discovers and develops novel therapeutics for the treatment of cardiovascular, cerebrovascular, and lower limb ischemic diseases. The firm identifies and develops new pathways and products for the treatment of vascular diseases. CliniGenetics was founded in 2000 and is headquartered in Nimes, France. | Health Technology |
| Arteria SA (France) | Commercial Services |
| Aurex SAS | |
| SAS Linerbenne |
- Börse
- Insiders
- Jean-Louis Falco
- Erfahrung
